Vylor raised the money, sent it up to the old DuPont entity that keeps the PFAS claims, and walked out the door. That bond is not the states’ best exhibit. It is Corteva’s.
Corteva split in two on October 1, 2026. Its seed business became Vylor (NYSE: VYLR), which had already issued $1.1 billion of investment-grade bonds, taken about $1.44 billion of its former parent’s bonds onto its own books, and drawn bank lines to fund an estimated $3.5 billion cash distribution to EIDP, the historical E. I. du Pont entity that stays with Corteva along with the legacy “forever chemicals” liabilities. Sixteen state and territorial governments sued on distribution day, calling the whole thing a fraudulent transfer.
Corteva’s stock “fell” more than 80% that Thursday. Nobody lost a dime on that line. Every holder of record got one Vylor share per Corteva share, and the value simply moved to a new ticker.
The number that actually matters is older and smaller: $1.1 billion, borrowed on August 31 by a company that was still a wholly owned subsidiary.
Most coverage will read that bond like every other leveraged spin-off. Parent pockets cash, child keeps the debt, creditors get stiffed. That is how DuPont’s 2015 Chemours spin worked, and it is roughly how Aramark’s Vestis spin worked. Vylor runs the same playbook in the opposite direction. The cash moved toward the liabilities, not away from them. Which makes the bond less of a smoking gun and more of a defense brief, and leaves the real fight somewhere nobody has a number yet: what the PFAS claims are worth.
What Happened
At 12:03 a.m. New York time on October 1, Corteva completed the separation of its seed segment, according to Vylor’s Form 8-K. Vylor holds Pioneer, Brevant and the rest of the seed franchise, which booked $9.9 billion of net sales in 2025. Vylor took Corteva’s seat in the S&P 500 the same day. What is left of Corteva, now a pure crop protection company, moved to the S&P MidCap 400.
The financing came first. On August 31, Vylor sold $550 million of 5.125% notes due 2031 and $550 million of 5.625% notes due 2036. Those proceeds were earmarked as a cash distribution to EIDP, described in the offering documents as partial payment for the seed business EIDP contributed to Vylor. Until the spin closed, EIDP guaranteed the new notes. At separation, that guarantee fell away automatically.
The second leg was a bond swap. EIDP had $1.6 billion outstanding across three series: 2.300% notes due 2030, 5.125% notes due 2032 and 4.800% notes due 2033. Vylor offered holders identical Vylor notes, same coupon, same maturity, same payment dates. According to Corteva’s final results release, holders tendered $1,438.6 million, or 89.9% of the total.
The legal fight ran right up to the wire. California moved for a temporary restraining order on September 14 in the federal PFAS litigation in South Carolina, backed by 20 states and nine municipalities. On September 30, the Fourth Circuit summarily reversed a district court order that had refused to let California file that motion, sending it back without ruling on the merits. The district court then denied the restraining order, noting California had known about the plan since at least December 2025. The spin closed hours later.
Then a second front opened. On October 1, 15 states and Guam filed suit in Marion County, Indiana, naming EIDP, Corteva and Vylor under the Uniform Voidable Transactions Act. Their complaint argues that Vylor received the “crown jewels” while assuming none of the PFAS liabilities. Corteva has called the states’ underlying PFAS claims “speculative and unproven,” Reuters reported, and says it never made or sold PFAS products.
By midday October 6, the market had delivered its own verdict on the split. Vylor’s equity was worth about $48.7 billion. New Corteva’s was worth about $9.3 billion.
The Backstory
To see why a seed company spin turned into a creditor fight, follow the corporate chain.
EIDP is the old DuPont, the company that made PFOA and other PFAS for decades. In 2015, it spun off its performance chemicals business as Chemours, which took the PFAS-heavy plants and, per the states’ complaint, paid DuPont a dividend of roughly $4 billion on the way out. Chemours later sued, arguing the liabilities it inherited had been badly underestimated.
In 2019, the DowDuPont merger unwound into three companies. Corteva became the parent of EIDP, which held the agriculture business. Corteva and the new DuPont contractually split Old DuPont’s PFAS exposure, 29% and 71% respectively after an initial shared tranche. A 2021 settlement with Chemours set up a $4 billion cost-sharing pool, with Corteva and DuPont capped at $2 billion combined. Corteva has put its own estimated share of that cap at about $600 million.
The bills kept arriving anyway. The complaint lists an $875 million New Jersey settlement entered in August 2026, a $455 million North Carolina settlement weeks before the spin, and a $1.185 billion class settlement with U.S. public water systems approved in 2024.
Through all of it, EIDP sat inside Corteva holding both businesses. And the two businesses were never equal.

Seed was 56.9% of Corteva’s 2025 sales. It produced $2.64 billion of the $3.99 billion in segment operating EBITDA, or 66.1%. And it now carries 84% of the two companies’ combined equity value.
That last gap is the story inside the story. Some of it is growth: seed has been compounding margins faster than crop chemicals. Some of it is the market charging a discount to whichever side kept the PFAS exposure. Either way, the states’ own complaint, which puts the split at roughly $40 billion versus $14 billion, actually understates the imbalance the market has now priced.
The Plan
Here is how the money moved, in order.
First, Corteva consolidated the seed business under Pioneer Hi-Bred, an EIDP subsidiary. EIDP then contributed Pioneer to Vylor. Vylor paid cash up to EIDP. EIDP passed the Vylor shares up to Corteva, and Corteva distributed them to its stockholders.
The cash leg was much bigger than the bond. Vylor’s information statement projected about $5.7 billion of debt at separation, built from four pieces:
- A $1.5 billion 364-day revolver, fully drawn
- About $1.58 billion drawn on a $3.0 billion five-year revolver
- The $1.1 billion of new notes
- Roughly $1.4 billion of notes swapped in from EIDP
Against that, an estimated $3.5 billion was to be distributed to New Corteva. Between July 1 and late September alone, Pioneer had already sent about $3.08 billion of cash up to EIDP.
Add the cash to the $1.44 billion of EIDP bonds that walked across to Vylor, and EIDP’s side of the ledger improved by roughly $4.9 billion. The states put the figure at about $5 billion, so on the arithmetic, everyone agrees.
The headline $1.1 billion bond, in other words, is about 19% of Vylor’s opening debt and about 22% of what EIDP received. It got the press release. The revolvers did most of the lifting.
Now the part that tells you what the professionals think. EIDP bondholders could stay put or swap into Vylor paper with identical terms. Early tenderers received less than $3 per $1,000 in cash on top. Late tenderers accepted $970 of Vylor principal for every $1,000 of EIDP principal, a 3% haircut, just to get out. And everyone who tendered also consented to strip nearly all the covenants from the EIDP notes left behind, about $161 million of them.
That is a market price on the question the states are litigating. Nearly nine out of ten bondholders chose the clean side, and some paid to get there. Debt follows the asset, not the old name on the indenture.
How does that compare with the classic cases?
| Chemours (2015) | Vestis (2023) | Vylor (2026) | |
|---|---|---|---|
| Cash sent to the parent | About $4 billion (per the states’ complaint) | About $1.457 billion | About $3.5 billion, plus $1.44 billion of debt assumed |
| Cash as a multiple of the spinco’s EBITDA | Not disclosed on a comparable basis | 3.6x | 1.3x |
| Where the legacy liabilities ended up | With the spinco | No comparable legacy pool | With the parent |
| Who complained | The spinco itself | The spinco’s shareholders | The parent’s creditors |
Vylor’s opening debt is about 2.2 times its 2025 seed EBITDA, before standalone public-company costs. Vestis opened at 3.95x net leverage. By the usual leveraged-spin yardstick, Vylor is the conservative version of the trade. BMA’s Vestis teardown shows what happens when the cash multiple runs high and the business stumbles. Vylor’s problem is different. Its risk is not that it borrowed too much. It is that someone wants a claim on what it owns.
The Business Model Angle
A spin-off is a dividend, so the bond sets the only price. A fraudulent-transfer claim generally needs two things: the debtor did not receive reasonably equivalent value, and it was left insolvent or thinly capitalized. A spin fails the first test almost by design, because the parent gets nothing for the shares it hands out. The cash the spinco pushes up is the entire consideration. That is why Corteva made independent solvency opinions for Vylor, EIDP and New Corteva a condition of closing. Every bond-funded spin is built to win on the second test.
The direction of the cash matters more than its size. Chemours and Vylor used the same toolkit, spinco debt funding a payment to the parent. In 2015 the cash moved away from the entity holding the liabilities. In 2026 it moved toward it. Same instruments, opposite creditor math. Anyone modeling a separation should draw that arrow before reading the press release, the same way a sale-leaseback is judged by who ends up holding the obligation, not by the size of the check.
Exchange offers are the fastest due-diligence desk in finance. Swapping old bonds for new paper, paired with a consent solicitation that strips covenants from anything left behind, lets an issuer migrate its debt to the entity it wants. When almost 90% of holders take the deal at nearly zero incentive, that participation rate is a public, real-money read on which side carries the risk. Founders and CFOs planning a carve-out should expect lenders to vote with their feet exactly this way.
The Risk
Start with the states’ case, because it is stronger than the “accounting drop” headlines suggest. Their math is simple. They say crop protection is worth about $14 billion while Old DuPont’s PFAS exposure runs into “tens of billions.” Add a U.S. pension and retiree benefit liability the complaint puts above $800 million. If a court agrees EIDP was left unable to pay its debts, the remedies requested include voiding the transfers to the extent needed, a constructive trust over what Vylor received, and an injunction barring Vylor from distributing that property. Vylor’s own information statement flagged fraudulent-conveyance exposure as a risk factor. The market’s 84% value share arguably helps the plaintiffs more than their own estimate does.
Now Corteva’s side, and it is not weak either. About $4.9 billion moved toward EIDP, not away. Independent solvency opinions were a closing condition. Corteva’s contractual share of the 2021 cost-sharing pool is capped, and its estimated portion is around $600 million. The seed business was never a PFAS business. Two federal courts declined to stop the deal, if only on procedural and timing grounds. And the states have not put a single dollar figure on what PFAS will ultimately cost, which is the number the solvency question depends on.
Then there is Vylor’s own balance sheet. About $5.7 billion of opening debt is manageable for a business that produced $2.64 billion of segment EBITDA last year, but $1.5 billion of it sits in a 364-day revolver that needs refinancing within a year. Seed sales are seasonal, front-loaded into the Northern Hemisphere planting window. A litigation overhang that lingers into refinancing season could cost more in spread than it ever costs in a courtroom.
Litigation like this rarely ends quickly. The Chemours fallout took six years, from the 2015 spin to the 2021 cost-sharing settlement.
Quick Questions
Did Corteva shareholders lose more than 80% on October 1? No. The price drop reflected the seed business leaving. Holders as of September 24 received one Vylor share per Corteva share, and Vylor now carries most of the value.
Did the Fourth Circuit rule against California on the merits? No. On September 30 it summarily reversed a district court order that had blocked California from filing its emergency motion, and sent the case back without ruling on the merits. The district court then denied the restraining order itself.
Who is responsible for the PFAS claims now? EIDP, the old DuPont entity, stays inside New Corteva along with Corteva’s share of the existing cost-sharing arrangements. Vylor assumed none of them. The new lawsuit asks a court to make Vylor’s assets available anyway.
Why would EIDP bondholders swap into Vylor notes? They got the same coupon and maturity from the company holding the seed business and none of the PFAS exposure. About 89.9% took the deal, and late tenderers even accepted a 3% haircut on principal.
What should investors watch next? Both companies report third-quarter results on November 11, 2026. Watch Vylor’s refinancing of the 364-day revolver, any request for an injunction on dividends in the Indiana case, and any number either side attaches to PFAS liabilities.
The Business Model Analyst Take
The $1.1 billion bond borrowed before Vylor existed as a public company did two jobs at once. It helped set the price of the seed business, and it built Corteva’s defense, because every dollar of it flowed toward the entity facing the claims. Comparing $4.9 billion to a $48.7 billion market value proves less than it seems, since every spin-off looks that lopsided by design. The question a court will actually ask is whether a crop chemicals business plus $4.9 billion can cover what Old DuPont owes. Nobody, including the 16 governments that sued, has put that number on paper. Until someone does, Vylor’s bondholders have already cast the only vote that counts in cash: nearly nine in ten moved across the line.
